Skip to main content

Table 3 Subgroup analyses for new onset diabetes mellitus

From: Association between ICS use and risk of hyperglycemia in COPD patients: systematic review and meta-analysis

Subgroup title No of trials No of participants Risk ratio (95% CI) P Value I2 (%)
Overall 8 33,340 1.04 (0.88–1.15) 0.95 0
Daily dose      
 Low dose 1 444 0.71 (0.03–17.41) 0.84  
 Medium dose 2 26,941 1.00 (0.87–1.14) 0.99 0
 High dose 5 5955 1.16 (0.53–2.54) 0.71 0
Duration      
 Less than 1 year 4 1844 0.70 (0.16–2.98) 0.63 0
 At least 1 year 4 31,496 1.01 (0.88–1.15) 0.91 0